Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
Efficacy of oral tofacitinib in moderate to severe alopecia areata, totalis and universalis at the tertiary care hospital, Karachi.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: November 17, 2025
Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience.
Journal: Journal of cutaneous medicine and surgery
Published: November 11, 2025
Remarkable Remission of Alopecia Totalis with Tofacitinib and Excimer.
Journal: Annals of African medicine
Published: June 24, 2025
Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.
Journal: Cureus
Published: April 18, 2025
Paradoxical psoriasis flare caused by tofacitinib in a patient with alopecia totalis.
Journal: Indian journal of dermatology, venereology and leprology
Published: March 17, 2025
Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis.
Journal: Frontiers in medicine
Published: February 10, 2025
Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis.
Journal: International journal of trichology
Published: November 13, 2024
Azathioprine-related alopecia totalis due to NUDT 15 mutation in a pregnant systemic lupus erythematosus patient with successful obstetric outcome.
Journal: Rheumatology (Oxford, England)
Published: August 02, 2024
Efficacy of baricitinib in moderate alopecia areata, severe alopecia areata, alopecia totalis, and alopecia universalis: A real-world comparative study.
Journal: Journal of the American Academy of Dermatology
Published: July 28, 2024
Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India.
Journal: Journal of cutaneous medicine and surgery
Published: July 26, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.
Journal: The Journal of dermatology
Published: July 11, 2024
Last Updated: 01/07/2026